Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PSB202 |
Trade Name | |
Synonyms | PSB-202|PSB 202 |
Drug Descriptions |
PSB202 is comprised of an anti-CD20 monoclonal antibody and an anti-CD37 monoclonal antibody, which potentially induces B-cell killing and tumor reduction (Cancer Res 2022;82(12_Suppl):Abstract nr 2902). |
DrugClasses | CD20 Antibody 24 CD37 Antibody 8 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PSB202 | PSB202 | 0 | 1 |